bioPmed
bioPmed is a Piedmont-based innovation cluster, founded in 2009 and managed by Bioindustry Park Silvano Fumero, that connects research institutions, companies, hospitals, and local health authorities to foster collaboration, funding access, and growth in the health and life sciences sector.
- Company typePrivate
- Founded2009
- HeadquartersTurin, Italy
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What bioPmed does
bioPmed is the reference innovation cluster for the health and life sciences sector of the Piedmont region in Italy, established in 2009 by the Piedmont Region under the POR-FESR 2007-2013 program and managed by Bioindustry Park Silvano Fumero S.p.A. Società Benefit. Its core product is a cluster membership and network platform that connects public and private research institutions, foundations, associations, startups, SMEs, large enterprises, hospitals, and local health authorities (ASL) into a single regional ecosystem. Functional offerings include connection and visibility services, access to funding and strategic support, collaborative innovation projects, supply chain project facilitation, international partnership brokering, and training; the cluster also publishes an annual innovation catalog showcasing members' products and services. Technology is limited to a standard WordPress website and member communications (newsletter, events, catalog); no proprietary software, API, or AI/ML systems are operated.
The business model is community-led and membership-based: bioPmed generates value by facilitating collaborative projects, brokering partnerships, and connecting members to regional and EU funding opportunities. Pricing is not publicly disclosed, and the organization is not structured as a venture-backed commercial enterprise; it operates as an association under the Bioindustry Park managing entity, with the core team consisting of 7 members led by Cluster Manager Sara Falvo. Revenue is not publicly disclosed and is likely a combination of regional/EU public funding, member contributions, and project grants, consistent with a small regional cluster organization. The cluster holds the ESCA Gold Label for Cluster Management Excellence (2015, after a 2013 Bronze Label) and is part of the Sistema Poli d'Innovazione Piemonte (2022), with internationalization partnerships including Biocom California (2026), CQIB in Québec (2026), and Consorzio Italbiotec (2026).
bioPmed firmographics
Firmographics- Name
- bioPmed
- Legal name
- BIOINDUSTRY PARK SILVANO FUMERO S.P.A. Società Benefit
- Website
- https://biopmed.eu
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- bioPmed is a Piedmont-based innovation cluster, founded in 2009 and managed by Bioindustry Park Silvano Fumero, that connects research institutions, companies, hospitals, and local health authorities to foster collaboration, funding access, and growth in the health and life sciences sector.
- Ownership category
- akta.pro rank
Where bioPmed is headquartered
LocationHeadquarters
- HQ city
- Turin
- HQ country
- Italy
- HQ region
- Europe
Offices2 records
Markets served
bioPmed business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Cluster Membership and Network Services: bioPmed generates value by connecting innovation actors, facilitating collaborative projects, and providing access to funding and partnership opportunities for member organizations in the healthcare and life sciences sector.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
bioPmed product offering
Product offeringCore offering
bioPmed is an innovation cluster that connects research institutions, companies, hospitals, and local health authorities in Piedmont's health and life sciences ecosystem. It delivers cluster membership services including networking, visibility for members, facilitation of collaborative innovation projects, supply chain development, access to regional and EU funding, training, and internationalization support. It is operated by Bioindustry Park Silvano Fumero S.p.A. Società Benefit and is not a product or software vendor but a cluster management organization.
Product overview
bioPmed is a Piemonte Innovation Cluster (Polo di Innovazione) for health and life sciences. It is not a product company but rather an innovation network/organization managed by Bioindustry Park Silvano Fumero S.p.A. Società Benefit. Its offerings consist of cluster membership services including: generating opportunities for innovative projects, stimulating competitiveness and growth of companies, creating connections between key regional actors, providing visibility to members, supporting innovation, offering training, and enhancing competitiveness. The organization maintains a catalog of innovations and coordinates various strategic projects among its member companies.
Differentiator
Problem solved
Functional benefit
Products and services
- Innovation Cluster Membership Services Cluster membership providing connection, visibility, innovation support, training, and competitiveness services to healthcare and life sciences organizations in Piedmont, Italy.
- Innovation Catalog Annual catalog showcasing life science products and services from bioPmed's regional innovation supply chain, providing visibility for member organizations.
Quantifiable outcome
- Cluster certified with Bronze Label (2013) and Gold Label (2015) by ESCA - European Secretariat for Cluster Analysis
Companies that use bioPmed
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
bioPmed technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
bioPmed partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered strategic, minor and core.
- CQIB (Centre Québécois d'Innovation en Biotechnologie)strategicCollaboration agreement between Bioindustry Park and CQIB signed during institutional mission to Canada, promoted by Regione Piemonte and CEIP Piemonte to strengthen innovation between Piedmont and Québec.
- Consorzio ItalbiotecstrategicbioPmed and Bioindustry Park entered the Italbiotec consortium to strengthen innovation, technology transfer, and internationalization.
- Biocom CaliforniastrategicMemorandum of Understanding signed between Bioindustry Park and Biocom California to strengthen the internationalization of the cluster.
- AI Skills AllianceminorBioindustry Park and bioPmed joined AI Skills Alliance to provide free training opportunities for their community.
- Sistema Poli d'Innovazione PiemontecorebioPmed became part of the Sistema Poli d'Innovazione Piemonte in 2022, connecting with other innovation clusters in the Piedmont region to strengthen the regional innovation ecosystem.
- Bioindustry Park Silvano Fumero S.p.A. Società BenefitcoreBioindustry Park is the managing entity (soggetto gestore) of bioPmed. Located at Via Ribes, 5 in Colleretto Giacosa, it provides administrative and technical support to the cluster. The data controller for personal data processing is Bioindustry Park Silvano Fumero S.p.A. Società Benefit.
- ESCA - European Secretariat for Cluster AnalysiscoreESCA provides certification for cluster management excellence. bioPmed received Bronze Label (2013) and Gold Label (2015) for cluster management excellence.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
bioPmed competitors and assessment
Company assessmentBroad incumbents
- EIT Health: Europe-wide health innovation partnership under the European Institute of Innovation & Technology. Functions as a much larger, pan-European cluster for health/life sciences, providing funding, accelerator programs, and matchmaking at a scale bioPmed operates within regionally.
Direct peers
- CQIB (Centre Québécois d'Innovation en Biotechnologie): Québec biotechnology innovation center that brokers collaboration between research institutions, SMEs, and global markets. Signed a collaboration agreement with bioPmed in 2026 and operates a structurally analogous cluster/innovation-brokering model for life sciences in its region.
- Cluster Alisei: Italian national biotech cluster organization that aggregates life sciences actors across regions. Directly comparable to bioPmed as a parallel cluster entity working with overlapping member types (research institutions, SMEs, large companies) to broker innovation projects, with which bioPmed is formally affiliated as a Sistema Poli d'Innovazione partner.
- Italbiotec: Italian biotechnology consortium focused on technology transfer and innovation in the life sciences. A near-direct peer: bioPmed itself joined the consortium in 2026, indicating functional overlap in R&D brokerage, technology transfer, and internationalization support for biotech members.
- Biocom California: California life sciences trade association and cluster convener. Signed an MoU with Bioindustry Park/bioPmed in 2026, confirming functional comparability in serving member companies with policy advocacy, networking, and international partnership access — across a different geography.
- Sistema Poli d'Innovazione Piemonte: Regional network of innovation clusters in Piedmont, of which bioPmed became a member in 2022. Comparable as a peer organization providing cluster-level coordination services, while also serving as the umbrella structure within which bioPmed operates.
- Cluster CEBR: Italian life sciences/biomedical cluster within the Sistema Poli d'Innovazione. Operates the same cluster-management business model as bioPmed, sharing the same national cluster framework and competing for similar member profiles and EU funding flows.
Regional players
- MedCity: UK-based life sciences cluster organization promoting collaboration between research, industry, and the NHS. Comparable to bioPmed in its role connecting academic, industry, and healthcare system stakeholders, though operating in a different European geography with stronger NHS-driven demand signals.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Customer concentration
bioPmed social profiles
Digital presencebioPmed financial estimates
Financial estimateRevenue estimate
Valuation estimate
bioPmed leadership team
Management profileNumber of profiles
Profiles7 records
bioPmed funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
bioPmed M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about bioPmed
What does bioPmed do?
bioPmed is an innovation cluster that connects research institutions, companies, hospitals, and local health authorities in Piedmont's health and life sciences ecosystem. It delivers cluster membership services including networking, visibility for members, facilitation of collaborative innovation projects, supply chain development, access to regional and EU funding, training, and internationalization support. It is operated by Bioindustry Park Silvano Fumero S.p.A. Società Benefit and is not a product or software vendor but a cluster management organization.
Is bioPmed a public or private company?
bioPmed is a private company. It is classified as corporate owned and is currently operating.
When was bioPmed founded?
bioPmed was founded in 2009. It employs 1,001 to 5,000 people.
Where is bioPmed based?
bioPmed is headquartered in Turin, Italy, in the Europe region.
How does bioPmed make money?
One revenue line is on record: cluster Membership and Network Services.
Who are bioPmed's main competitors?
EIT Health is listed as a broad incumbent. Direct peers are CQIB (Centre Québécois d'Innovation en Biotechnologie), Cluster Alisei, Italbiotec, Biocom California, Sistema Poli d'Innovazione Piemonte and Cluster CEBR. MedCity is listed as a regional player.
Does bioPmed have an API?
No public API is recorded for bioPmed.